Scientia Clinical Research (SCR) is the first publicly funded purpose built early phase clinical trials centre in UNSW. We will conduct first-in-human and first-in-patient studies in cancer and across other disciplines, both for novel therapies as well as methods of disease diagnosis and detection. As part of the Bright Alliance with Prince of Wales Hospital, the Royal Hospital for Women, Sydney Children's Hospital and UNSW, Scientia will provide a research hub and state of the art clinical care.
After completing my FRACP in medical oncology in the SESIAHS network, I worked for 4 years in London at an early phase clinical trials unit, Sarah Cannon Research UK, and completed a MD(res) at University College London. For my MD(res), I researched biomarker development in endometrial cancer including circulating tumour cells and methylation studies.
I have experience in managing phase I-III clinical trials across a spectrum of tumour streams and molecular targets including immunotherapy, PI3K/Akt, RAF/MEK, FAK, FGFR and others.